PROTHENA CORPORATION PUBLIC LIMITED COMPANY Operating Leases, Future Minimum Payments, Due in Three Years
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Operating Leases, Future Minimum Payments, Due in Three Years of $0 as of 2018-12-31, per its 10-K filed 2020-03-03.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2020-03-03
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $0.00.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $240.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $242.00K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Three Years $255.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2020-03-03 |
| 2018-09-30 | $240.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $242.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $255.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $248.00K 10-K · filed 2018-02-26 |
| 2017-09-30 | $245.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $236.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $221.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.40M 10-K · filed 2017-02-27 |
| 2016-09-30 | $2.33M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $2.33M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $7.25M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $2.32M 10-K · filed 2016-02-25 |
| 2014-12-31 | $2.02M 10-K · filed 2015-03-13 |
| 2014-09-30 | $1.94M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $1.93M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $1.93M 10-Q · filed 2014-05-05 |
| 2013-12-31 | $1.93M 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |